Answers are grounded in this paper and cite their sources.
Analysis reveals FDG PET/CT predicts progression-free survival after chemotherapy in colorectal liver metastases before transplantation.
BACKGROUND AND AIMS: F]FDG PET/CT after chemotherapy, with patients presenting with low or high metabolic tumor volume (MTV). METHODS: F]FDG PET/CT, and patients with CMR (MTV = 0) were identified. Patients were stratified into three subgroups: MTV 0, MTV low, and MTV high. DFS, OS, and PRS were compared using the Kaplan-Meier method and the log-rank test. Baseline characteristics and CT reassessment data were analyzed using the Mann-Whitney U test for continuous variables and Fisher's exact test for categorical variables. RESULTS: = 0.010 and <0.001), including after exclusion of the MTV high group (0.034 and <0.001). CONCLUSION: F]FDG PET/CT after chemotherapy prior to liver transplantation for CRLM had intermediate DFS, OS, and PRS compared with patients with low and high MTV.
No takes yet. Share an insight, caveat, or question.
Stern et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: